A North Carolina-based lab company will pay the federal government up to $43 million to settle allegations that it billed Medicare and other federal programs for unnecessary tests, the Department of Justice said.
Genova Diagnostics Inc. will surrender $17 million in pending claims submitted to Medicare and the TRICARE program, the DOJ said in a statement issued Monday. It also agreed to send the government a percentage of its annual revenues above $100 million for the next five years, not to exceed an additional $26 million.
A whistleblower said Genova focuses on the “functional medicine market,” a form of alternative ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.